BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dovrolis N, Kolios G, Spyrou G, Maroulakou I. Laying in silico pipelines for drug repositioning: a paradigm in ensemble analysis for neurodegenerative diseases. Drug Discov Today 2017;22:805-13. [PMID: 28363518 DOI: 10.1016/j.drudis.2017.03.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Firth A, Prathapan P. Broad-spectrum therapeutics: A new antimicrobial class. Curr Res Pharmacol Drug Discov 2021;2:100011. [PMID: 34870144 DOI: 10.1016/j.crphar.2020.100011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Usman A, Khan FF. Identification of antineoplastic agents for oral squamous cell carcinoma: an integrated bioinformatics approach using differential gene expression and network biology.. [DOI: 10.1101/2021.10.14.464376] [Reference Citation Analysis]
3 Chrétien B, Jourdan JP, Davis A, Fedrizzi S, Bureau R, Sassier M, Rochais C, Alexandre J, Lelong-Boulouard V, Dolladille C, Dallemagne P. Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease. Br J Clin Pharmacol 2021;87:2830-7. [PMID: 33274491 DOI: 10.1111/bcp.14690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Masoudi-Sobhanzadeh Y, Masoudi-Nejad A. Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm. BMC Bioinformatics 2020;21:313. [PMID: 32677879 DOI: 10.1186/s12859-020-03644-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
5 Jourdan JP, Bureau R, Rochais C, Dallemagne P. Drug repositioning: a brief overview. J Pharm Pharmacol 2020;72:1145-51. [PMID: 32301512 DOI: 10.1111/jphp.13273] [Cited by in Crossref: 72] [Cited by in F6Publishing: 80] [Article Influence: 36.0] [Reference Citation Analysis]
6 Alaimo S, Pulvirenti A. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions. Methods Mol Biol 2019;1903:97-113. [PMID: 30547438 DOI: 10.1007/978-1-4939-8955-3_6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 8.3] [Reference Citation Analysis]
7 Masoudi-Sobhanzadeh Y, Omidi Y, Amanlou M, Masoudi-Nejad A. DrugR+: A comprehensive relational database for drug repurposing, combination therapy, and replacement therapy. Comput Biol Med 2019;109:254-62. [PMID: 31096089 DOI: 10.1016/j.compbiomed.2019.05.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
8 Dovrolis N, Filidou E, Kolios G. Systems biology in inflammatory bowel diseases: on the way to precision medicine. Ann Gastroenterol 2019;32:233-46. [PMID: 31040620 DOI: 10.20524/aog.2019.0373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
9 Kim IW, Jang H, Kim JH, Kim MG, Kim S, Oh JM. Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles. Sci Rep 2019;9:2660. [PMID: 30804389 DOI: 10.1038/s41598-019-39228-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
10 Karatzas E, Kolios G, Spyrou GM. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures. Methods in Molecular Biology 2019. [DOI: 10.1007/978-1-4939-8955-3_9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
11 Barbieri F, Würth R, Pattarozzi A, Verduci I, Mazzola C, Cattaneo MG, Tonelli M, Solari A, Bajetto A, Daga A, Vicentini LM, Mazzanti M, Florio T. Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability. Front Pharmacol 2018;9:899. [PMID: 30186163 DOI: 10.3389/fphar.2018.00899] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
12 Zloh M, Kirton SB. The benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions. Future Med Chem 2018;10:423-32. [PMID: 29380627 DOI: 10.4155/fmc-2017-0151] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
13 He J, Yan H, Cai H, Li X, Guan Q, Zheng W, Chen R, Liu H, Song K, Guo Z, Wang X. Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning. J Transl Med 2017;15:198. [PMID: 28962576 DOI: 10.1186/s12967-017-1302-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]